معرفی
Andreas Palm is an Associate Professor at Uppsala University's Department of Medical Sciences, specializing in Lung, Allergy and Sleep Research. His work focuses on respiratory medicine with particular emphasis on chronic obstructive pulmonary disease (COPD), sleep disorders, and long-term respiratory support systems.
Dr. Palm's research interests center around COPD progression, phenotypes, and management strategies. He has made significant contributions to understanding sleep-disordered breathing including obstructive sleep apnea and obesity hypoventilation syndrome. A substantial portion of his work examines home mechanical ventilation, including implementation protocols, adherence factors, and long-term outcomes for patients with chronic respiratory failure. His research often addresses the intersection of socioeconomic factors with treatment adherence and health outcomes.
Analysis of Dr. Palm's recent publications reveals a strong focus on large population-based cohort studies, particularly the DISCOVERY study examining patients on long-term respiratory support. His work combines clinical epidemiology with patient-centered outcomes research, examining how socioeconomic factors impact treatment adherence and health outcomes. Recent trends show increasing attention to the intersection of respiratory disease with other conditions like cancer, as well as the impact of the COVID-19 pandemic on patients with pre-existing respiratory conditions.
Dr. Palm has been instrumental in developing and validating national registry studies in Sweden, including the Swedish sleep apnea registry (SESAR) and the DISCOVERY cohort, which track patients receiving continuous positive airway pressure, mechanical ventilation, and oxygen therapy. These registry-based studies provide valuable real-world evidence on treatment effectiveness across diverse patient populations.
His research bridges clinical care and population health, providing evidence that informs both individual patient management and healthcare policy decisions. Current work examines biomarkers for predicting COPD exacerbations, oxygen therapy duration effects, and the transition of care for young adults moving from pediatric to adult respiratory services.
